Search

everythinglearnresearchcommunity

for

Search:↓

HIV can cause unusual and severe skin problems that are hard to treat.

CRTH2 antagonists might be useful for treating many conditions because they play a role in immune and inflammation responses.

Frontal fibrosing alopecia in families shows similar signs to individual cases and may have a genetic link.

Bee venom can help stem cells promote hair growth.

Higher cell number PRP improves hair density and diameter more than lower cell number PRP.

New methods to test hair growth treatments have been developed.

Neoadjuvant chemotherapy followed by surgery leads to fewer severe complications and better quality of life than immediate surgery in advanced ovarian cancer patients with high tumor load.

Platelet-rich plasma (PRP) is effective in treating various skin conditions and improving hair density, thickness, and patient satisfaction, with lower relapse rates for Alopecia Areata.

CBD may improve skin and hair health, but its effective use and safety need more research.

Trichoscopy effectively diagnoses and assesses the severity of androgenetic alopecia.

The Wnt/β-catenin pathway is important for body functions and diseases, and targeting it may treat conditions like cancer, but with safety challenges.

Dissolving microneedles show promise for delivering medication through the skin but face challenges like manufacturing complexity and regulatory hurdles.

Low Vitamin D receptor levels in breast cancer are linked to worse outcomes and more bone metastases, and could be a marker for prognosis.

Blood tests can help understand the genetic differences in people with alopecia areata, including how severe it is and if it's inherited.

Certain gene variants may contribute to high androgen levels in women with polycystic ovary syndrome.

Agaricus bisporus derived β-Glucan could be an effective cervical cancer treatment with antimicrobial and antioxidant properties.

Seborrheic dermatitis may contribute to the development of central centrifugal cicatricial alopecia.

Lower growth factors linked to balding in androgenetic alopecia.

The study found that Keratosis Pilaris Atrophicans is a genetic skin condition that starts in childhood, involves inflammation and scarring, and current treatments are only somewhat effective.

New research is needed to create better drugs that block the enzyme responsible for conditions like male baldness and prostate enlargement.

Minoxidil can stop the growth of ovarian cancer cells without harming the heart.

Rare adrenal cancers that secrete androgens or estrogens have a poor prognosis and are treated primarily with surgery.

Men with certain types of baldness at age 45 may have a higher risk of colon cancer and colorectal adenoma.

5α-reductase inhibitors help treat disorders caused by DHT and have potential for future therapies.

Fibroblast growth factor receptor signaling controls cell development and repair, and its malfunction can cause disorders and cancer, but it also offers potential for targeted therapies.

A woman developed psoriasis after taking certolizumab pegol, improving after stopping the drug and starting other treatments.

Hormone imbalances can cause skin diseases, and understanding these links is important for diagnosis and treatment.

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.

Balancing treatment effectiveness with side effects is crucial for relapsed follicular non-Hodgkin's lymphoma, especially in older patients.

5α-reductase inhibitors don't stop bladder cancer from developing or getting worse.